Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:41:07.702Z.
Calculation as of: 2026-10-06T19:41:07.702Z.
Quote observation: 2026-10-06T19:34:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 416ecde9e74d9373f9380d00a8c5b89f0781d1fb8694113a8adf0a2929208a5a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2013-08-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$15.54M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.11M
EV/FCF Ratio
11.89x
TTM Avg
13.15x
3Y Avg
13.15x
5Y Avg
13.15x
Market Cap
$14.18M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.43M
EV/FCF Ratio
N/A
TTM Avg
47.06x
3Y Avg
54.97x
5Y Avg
55.49x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $15.24M | N/A | N/A | N/A | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.71M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $14.80M | N/A | N/A | N/A | N/A |
| Jin Medical International Ltd. (ZJYL)vs › | $15.54M | N/A | N/A | N/A | N/A |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 79.94x | 79.62x | 79.62x |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | N/A | N/A | N/A | N/A |
| Vyome Holdings, Inc. (HIND)vs › | $14.11M | 11.89x | 13.15x | 13.15x | 13.15x |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.18M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.43M | N/A | 47.06x | 54.97x | 55.49x |
| Sintx Technologies, Inc. (SINT)vs › | $13.99M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2013-08-14 | 93.74x |
| 2013-08-13 | 93.74x |
| 2013-08-12 | 93.74x |
| 2013-08-09 | 93.74x |
| 2013-08-08 | 93.74x |
| 2013-08-07 | 93.74x |
| 2013-08-06 | 93.74x |
| 2013-08-05 | 93.74x |
| 2013-08-02 | 93.74x |
| 2013-08-01 | 93.74x |
| 2013-07-31 | 93.74x |
| 2013-07-30 | 93.74x |
| 2013-07-29 | 93.74x |
| 2013-07-26 | 93.74x |
| 2013-07-25 | 93.74x |
| 2013-07-24 | 93.74x |
| 2013-07-23 | 93.74x |
| 2013-07-22 | 93.74x |
| 2013-07-19 | 95.38x |
| 2013-07-18 | 95.38x |
| 2013-07-17 | 95.38x |
| 2013-07-16 | 95.38x |
| 2013-07-15 | 95.38x |
| 2013-07-12 | 95.38x |
| 2013-07-11 | 95.38x |
| 2013-07-10 | 95.38x |
| 2013-07-09 | 97.01x |
| 2013-07-08 | 97.01x |
| 2013-07-05 | 97.01x |
| 2013-07-03 | 97.01x |
| 2013-07-02 | 97.01x |
| 2013-07-01 | 97.01x |
| 2013-06-28 | 97.01x |
| 2013-06-27 | 97.01x |
| 2013-06-26 | 97.01x |
| 2013-06-25 | 97.01x |
| 2013-06-24 | 52.97x |
| 2013-06-21 | 97.01x |
| 2013-06-20 | 97.01x |
| 2013-06-19 | 97.01x |
| 2013-06-18 | 97.01x |
| 2013-06-17 | 97.01x |
| 2013-06-14 | 97.01x |
| 2013-06-13 | 97.01x |
| 2013-06-12 | 97.01x |
| 2013-06-11 | 105.16x |
| 2013-06-10 | 105.16x |
| 2013-06-07 | 105.16x |
| 2013-06-06 | 105.16x |
| 2013-06-05 | 105.16x |
| 2013-06-04 | 105.16x |
| 2013-06-03 | 105.16x |
| 2013-05-31 | 105.16x |
| 2013-05-30 | 105.16x |
| 2013-05-29 | 105.16x |
| 2013-05-28 | 105.16x |
| 2013-05-24 | 105.16x |
| 2013-05-23 | 105.16x |
| 2013-05-22 | 105.16x |
| 2013-05-21 | 105.16x |
| 2013-05-20 | 105.16x |
| 2013-05-17 | 105.16x |
| 2013-05-16 | 105.16x |
| 2013-05-15 | 105.16x |
| 2013-05-14 | 105.16x |
| 2013-05-13 | 105.16x |
